e-learning
resources
Madrid 2019
Tuesday, 01.10.2019
Immunopathological mechanisms of lung disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Late Breaking Abstract - Identification and functional testing of a novel receptor for SP-A on eosinophils
A. Dy (Tucson, United States of America), N. Barker (Tucson, United States of America), P. Langlais (Tucson, United States of America), J. Ledford (Tucson, United States of America)
Source:
International Congress 2019 – Immunopathological mechanisms of lung disease
Session:
Immunopathological mechanisms of lung disease
Session type:
Thematic Poster
Number:
4093
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Dy (Tucson, United States of America), N. Barker (Tucson, United States of America), P. Langlais (Tucson, United States of America), J. Ledford (Tucson, United States of America). Late Breaking Abstract - Identification and functional testing of a novel receptor for SP-A on eosinophils. 4093
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The impact of anti-IgE treatment on the airway microbiome in asthma.
Bronchoalveolar lavage (techniques, indications, results)
Altered microRNA profiles in the bronchoalveolar lavage fluid exosomes in asthma and COPD
Related content which might interest you:
Late Breaking Abstract - SARS-CoV-2 induces hyperinflammation in human macrophages via TLR4
Source: Virtual Congress 2021 – Late breaking basic and translational science of SARS-Cov2 and COVID-19
Year: 2021
Late Breaking Abstract: Alveolar epithelial function in mouse lungs: A novel real-time measurement of barrier properties
Source: Annual Congress 2010 - Novel insights into the pathophysiology of asthma and COPD
Year: 2010
Late Breaking Abstract - Functional investigation of the corticosteroid resistance candidate FKBP5 using a CRISPR-Cas9 knockout model
Source: International Congress 2017 – Novel molecular and genetic targets in COPD
Year: 2017
Late Breaking Abstract - Role of Muscarinic M3 receptors in bronchial remodelling of severe asthma
Source: International Congress 2017 – Late-breaking findings in asthma and COPD
Year: 2017
Late Breaking Abstract - Generating iPSC derived alveolar macrophages as a novel model for respiratory research
Source: International Congress 2019 – Novel methods, diagnostics and biomarkers in chronic lung diseases
Year: 2019
Late Breaking Abstract - Assessment of a ciliary transport protein in airway cells reveals novel pattern in cystic fibrosis
Source: International Congress 2017 – Cystic fibrosis: clinical issues
Year: 2017
Late Breaking Abstract - Role of interleukin-10 in normal and aberrant late lung development
Source: International Congress 2017 – Postnatal lung growth and development
Year: 2017
Late Breaking Abstract - IL-36 receptor agonists contribute to a pro-inflammatory milieu in smokers with and without COPD
Source: International Congress 2017 – New immune markers for asthma and COPD
Year: 2017
Late Breaking Abstract - Role of HIF2a oxygen sensing pathway in bronchial epithelium biology
Source: International Congress 2017 – Novel molecular and genetic targets in COPD
Year: 2017
Late Breaking Abstract - Title: Air-born allergens modulate the immunological lung microenvironment.
Source: International Congress 2017 – Novel mechanisms in asthma
Year: 2017
Late Breaking Abstract - Roles for transglutaminases in normal and aberrant lung development associated with BPD.
Source: International Congress 2017 – Late-breaking findings in pulmonary diseases
Year: 2017
Late Breaking Abstract - Intra-alveolar neutrophil-derived microvesicles: a biomarker of COPD severity
Source: International Congress 2018 – Advanced profiling of immune cells in chronic lung diseases
Year: 2018
Late Breaking Abstract - Differentially expressed exosomal miRNAs target key inflammatory pathways in COPD.
Source: International Congress 2018 – Advanced profiling of immune cells in chronic lung diseases
Year: 2018
Late Breaking Abstract - Pharmacological characterization of T cell-induced broncho-constriction in vitro and in vivo
Source: International Congress 2018 – Novel immunology-based therapies in asthma and COPD
Year: 2018
Late Breaking Abstract: The role of galectin-3 on macrophages in CNT-induced mouse lung inflammation
Source: Annual Congress 2010 - Macrophages: cell biology and disease-specific characteristics
Year: 2010
Late Breaking Abstract - Transient Receptor Potential Vanilloid subtype 4 in patients with lung cancer
Source: Virtual Congress 2020 – Biological aspects of lung cancer
Year: 2020
Late Breaking Abstract - Temporal relationships of cytokines, chemokines and cellular biomarkers during Human Rhinovirus (HRV) infection in asthmatics
Source: International Congress 2019 – Blood eosinophils and more in airway diseases
Year: 2019
Acute phase protein alpha1-antitrypsin - A novel regulator of angiopoietin-like protein 4 transcription and secretion in human cells
Source: International Congress 2014 – Mechanisms of COPD: proteases and a whole lot more
Year: 2014
Late Breaking Abstract - Human lung microbiota-driven differential innate immune landscape
Source: Virtual Congress 2021 – In vitro modelling of lung disease: reach out to the next dimension
Year: 2021
Late Breaking Abstract - Blood and bronchoalveolar neutrophil signatures associate with COPD severity
Source: Virtual Congress 2021 – Patient-reported outcome measures (PROMs): easy tools in the management of chronic respiratory diseases
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept